Skip to main content
. 2017 Sep 5;8:222. doi: 10.3389/fendo.2017.00222

Table 1.

Inter-group comparison for the whole group.

Arterial hypertension group (AHG) n = 114 Cushing’s disease (CD) n = 22 Healthy volunteers (HV) n = 35 p-Value Post hoc tests
Age (years), mean ± SD 46.3 ± 9.3 42.9 ± 12.5 43.8 ± 9.1 0.180
HR (bpm), mean ± SD 68.1 ± 8.7 73.9 ± 10.3 66.6 ± 11.7 0.016 AHG vs HV*
HV vs CD*
Systolic blood pressure (mmHg), mean ± SD 120.7 ± 9.5 123.2 ± 13.8 114.5 ± 10.1 0.002 AHGvs HV**
HV vs CD**
Diastolic blood pressure (mmHg), mean ± SD 77.9 ± 7.3 80.8 ± 9.7 72.3 ± 8.0 0.0001 AHG vs HV#
HV vs CD#
Body mass index (kg/m2), mean ± SD 30.9 ± 21.7 31.8 ± 7.1 25.8 ± 3.2 0.301
Echocardiography
LVH, n (%) 17 (14.9) 9 (40.9) 3 (8.6) 0.002
LVDD, n (%) 16 (14.0) 9 (40.9) 0 (0.0) 0.00005
LVEDD (mm), mean ± SD 48.4 ± 3.8 47.2 ± 4.0 48.4 ± 4.2 0.430
RVEDD (mm), mean ± SD 30.5 ± 3.2 30.4 ± 4.3 28.7 ± 4.0 0.036 AHG vs HV*
LA (mm), mean ± SD 37.3 ± 3.4 36.5 ± 3.9 35.0 ± 3.2 0.003 AHG vs HV**
Left ventricular mass index (g/m2), mean ± SD 90.1 ± 18.0 101.9 ± 22.7 83.4 ± 20.1 0.004 AHG vs CD*
HV vs CD**
LVEF (%), mean ± SD 66.4 ± 3.2 66.9 ± 3.3 67.5 ± 3.5 0.256
GLS (%), mean ± SD −19.2 ± 2.4 −17.7 ± 2.0 −20.0 ± 2.3 0.004 AHG vs CD*
HV vs CD**
E/A (–), mean ± SD 1.15 ± 0.34 1.00 ± 0.28 1.25 ± 0.33 0.025 HV vs CD*
E′ (cm/s), mean ± SD 10.4 ± 2.6 9.7 ± 3.7 12.6 ± 2.6 0.00006 AHGvs HV#
E/e′, mean ± SD 7.0 ± 1.9 7.2 ± 1.7 5.9 ± 1.2 0.003 HV vs CD#

*p < 0.05; **p < 0.01; #p < 0.001.

E/A, mitral flow early (E) and late (A) phase ratio; E/e′, mitral flow early (E) phase and mitral septal annulus early diastolic velocity (e′) ratio; GLS, global longitudinal strain; LA, left atrium diameter; LVDD, left ventricular diastolic dysfunction; LVEDD, left ventricular end diastolic diameter; LVEF, left ventricular ejection fraction; LVH, left ventricular hypertrophy; RVEDD, right ventricular end diastolic diameter.